Worldwide, osteoporosis causes more than 8.9 million fractures annually
1st Generic Teriparatide in the world backed by clinical trial
For patients who are suffering from fragility fractures due to osteoporosis
​
Rebuild your bones..Restore your strength.. Regains quality of life
Osteotide is an injection containing (Teriparatide – rh ParaThyroid Hormone (1-34) used for the management of severe osteoporosis. It is indicated for the treatment of patients with severe osteoporosis and are at high risk of fragility fractures.
Osteotide can be used in both male and female suffering from osteoporosis.
Once a day administration of Teriparatide increases new bone on trabecular, endocortical and periosteal bone surfaces.
1st Generic Teriparatide in the world backed by clinical trial
Osteotide is a recombinant human parathyroid hormone analogue, can be used for the treatment of Postmenopausal women with osteoporosis.
​
It simulates new bone formation and improves the skeletal micro-structure.
​
Also,Osteotide can be used to increase bone mass in men who are suffering from hypogonadal osteoporosis.
​
Osteotide is an injection containing (Teriparatide – rh ParaThyroid Hormone (1-34) used for the management of severe osteoporosis. It is indicated for the treatment of patients with severe osteoporosis and are at high risk of fragility fractures.
Osteotide can be used in both male and female suffering from osteoporosis.
Once a day administration of Teriparatide increases new bone on trabecular, endocortical and periosteal bone surfaces.
Osteotide is a recombinant human parathyroid hormone analogue, can be used for the treatment of Postmenopausal women with osteoporosis.
​
It simulates new bone formation and improves the skeletal micro-structure.
​
Also,Osteotide can be used to increase bone mass in men who are suffering from hypogonadal osteoporosis.
​
Rebuild your bones..Restore your strength.. Regains quality of life
